Metropolitan Life Insurance Company (MetLife)’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-14,775	Closed	-$204K	–	2692
2014 Q2	$204K	Buy	+14,775	New	+$204K	﹤0.01%	2496